1.

Effect on surgical decisions: ulipristal acetate as key player in Belgian phase IV registration trial

2.

Effect on surgical decisions: ulipristal acetate as key player in Belgian phase IV registration trial

3.

Effect on surgical decisions: ulipristal acetate as key player in Belgian phase IV registration trial

1.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients.

1.

Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.

1.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients

2.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients

3.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients

4.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients

5.

Quality of surgery and treatment and its association with hospital volume: A population-based study in more than 5000 Belgian ovarian cancer patients

1.

Centralizing surgery for ovarian cancer in a ‘non-centralizing’ country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experience

1.

Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study

2.

Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study

3.

Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study

1.

Centralizing surgery for ovarian cancer in a ‘non-centralizing’ country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experience

2.

Centralizing surgery for ovarian cancer in a ‘non-centralizing’ country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experience

3.

Centralizing surgery for ovarian cancer in a ‘non-centralizing’ country (Belgium): the UNGO (UCLouvain Network of Gynaecological Oncology) experience